Bone Allograft
-
Spine
Orthofix Announces Publication of Data Demonstrating the Clinical Benefits of Trinity Elite Cellular Bone Allograft in Lumbar Fusion Procedures
LEWISVILLE, TEXAS, December 22, 2022 –(BUSINESS WIRE)– Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and…
Read More » -
Financial
Global Bone Allografts Market Report (2022 to 2030) – Featuring Medtronic, Zimmer Biomet, Stryker and Lynch Biologics Among Others
Dublin, Sept. 29, 2022 (GLOBE NEWSWIRE) — The “Bone Allografts Market Size, Share & Trends Analysis Report by Application (Dental, Spine),…
Read More » -
Biologics
Aurora Spine receives IRB approval to commence registration for Multicenter Study of its SiLO™ Device for SI Joint Pain
CARLSBAD, Calif., May 06, 2021 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF),…
Read More » -
Biologics
NuVasive Expands Biologics Portfolio To Meet Clinical And Economic Needs
SAN DIEGO, Sept. 24, 2018 /PRNewswire/ — NuVasive, Inc. (NASDAQ :NUVA ), the leader in spine technology innovation, focused on transforming spine surgery with…
Read More »